Core Viewpoint - Patagonia Gold Corp. reported its financial results for Q3 2025, highlighting production and sales figures, ongoing construction projects, and exploration activities in Argentina [1][6]. Financial Performance - The company generated revenue of US$3 million in Q3 2025 [6]. - Residual production from Cap Oeste yielded 482 gold equivalent ounces produced and 707 gold equivalent ounces sold during the quarter [6]. Production and Sales - The production consisted of 273 gold ounces and 18,900 silver ounces, while sales included 478 gold ounces and 20,398 silver ounces, converted to a gold equivalent using an average spot market price ratio of 86.73:1 for the quarter [3][6]. Project Development - Construction of the Calcatreu heap leach facility in Rio Negro is progressing, with the access road, camp, explosives magazine, fuel storage tanks, and power generation plant completed [6]. - The relocation and refurbishment of the carbon in columns (CIC) plant from the Lomada de Leiva mine to Calcatreu has been completed, with installation expected in December 2025 [6]. - The elution, electro winning, and doré furnace circuits are scheduled for delivery in Q1 2026 [6]. Exploration Activities - The company incurred exploration expenditures of US$0.5 million in Q3 2025, with drilling totaling 1,074.35 meters at various targets [6]. - A total of 92.45 meters of trench were excavated, and 535.71 line-kilometers of ground magnetics surveying were completed [6].

Bringing Cholesterol-Lowering Injections to U.K. Community PharmaciesVANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) is pleased to announce HealthTab™ is being deployed in a new pilot launched by Barts Health NHS Trust, in collaboration with UCL Partners and the British Heart Foundation (BHF), to deliver inclisiran cholesterol-lowering injections through community pharmacies. Key Highlights HealthTab™ enters secondary-prevention ...

Core Viewpoint - Freehold Royalties Ltd. announces the departure of Chief Operating Officer Robert King and the elimination of the COO role as part of a restructuring strategy to align with the company's new operating structure [1]. Group 1: Management Changes - Robert King has left his position as Chief Operating Officer after six years with the company, contributing to its North American growth strategy [1]. - The company will redistribute the responsibilities of the COO role across the existing executive team following the termination of the management agreement with Rife Resources Ltd. [1]. Group 2: Company Overview - Freehold Royalties Ltd. is a leading North American energy royalty company, holding approximately 6.1 million gross acres in Canada and about 1.2 million gross drilling acres in the United States [2]. - The company's common shares are traded on the Toronto Stock Exchange under the symbol FRU [2].

Core Points - Western Pacific Trust Company (WP) has appointed Catherine Schaeffer as Vice-President, Operations, effective January 1, 2026, pending regulatory approval [1] - Ms. Schaeffer will be responsible for overseeing operational performance and developing continuous improvement initiatives within the organization [2] - Catherine Schaeffer has 23 years of experience in senior positions at the company and is recognized for her leadership and operational excellence [3] Company Overview - Western Pacific Trust Company is a licensed trust company authorized to conduct non-deposit taking trust business in British Columbia, Alberta, and Saskatchewan [5]

Core Points - Encore Technologies Corp. has successfully completed its initial public offering, raising gross proceeds of $862,500 through the issuance of 5,750,000 common shares at a price of $0.15 per share [1][2] - The offering was led by Leede Financial Inc., which received a cash commission of $60,375 and 402,500 non-transferable share purchase warrants [2] - The net proceeds from the offering will be used for growth initiatives, corporate development, and general working capital [3] Group 1 - The shares of Encore Technologies Corp. will begin trading on the Canadian Securities Exchange under the symbol "ENCR" on or about November 28, 2025 [3] - The company focuses on building and investing in technology ventures that enhance intelligent infrastructure, energy systems, and data optimization [4] - Encore Technologies Corp. aims to improve efficiency, transparency, and sustainability in real-world systems through data and automation [4]

Core Viewpoint - Orca Energy Group Inc. reported strong operational results in Q3 2025, with a 7% increase in gas deliveries over the quarter and a 4% increase year-to-date, driven by higher industrial consumption and demand for services and products [2][3]. Financial Performance - Revenue decreased by 12% to $21.7 million for Q3 2025 and by 4% to $71.4 million for the nine months ended September 30, 2025, primarily due to increased revenue share for the Tanzanian Petroleum Development Corporation (TPDC) [3][6]. - Net income attributable to shareholders surged by 834% to $19.5 million for Q3 2025 and by 889% to $42.0 million for the nine months ended September 30, 2025, mainly due to the reversal of loss allowance and recognition of interest income from TANESCO [3][6]. - Net cash flows from operating activities increased by 215% to $32.3 million for Q3 2025 and by 306% to $84.5 million for the nine months ended September 30, 2025, attributed to higher payments from TANESCO [3][6]. Operational Highlights - Daily average gas delivered and sold increased by 7% to 71.1 MMcfd for Q3 2025 and by 4% to 70.5 MMcfd year-to-date [6]. - Industrial gas deliveries rose by 18% to 20.9 MMcfd for Q3 2025 and by 32% to 19.5 MMcfd year-to-date, while power gas deliveries increased by 3% to 50.2 MMcfd for Q3 2025 but decreased by 4% year-to-date [6]. Legal and Regulatory Matters - The company is actively managing ongoing legal proceedings in Tanzania, including a dispute with Swala Oil & Gas (Tanzania) Plc, which claims damages of approximately $238 million [4][5]. - An anti-suit injunction was filed against Swala in the High Court of England and Wales to prevent them from pursuing claims in Tanzania [8]. - The company has submitted Requests for Arbitration to the International Centre for Settlement of Investment Disputes (ICSID) against the Government of Tanzania for breaches of investment protections [8]. Capital Expenditures and Financial Position - Capital expenditures decreased significantly by 98% to $0.2 million for Q3 2025 and by 94% to $0.8 million for the nine months ended September 30, 2025, primarily due to deferred projects [3][6]. - The company ended Q3 2025 with cash and cash equivalents of $127.9 million and working capital of $56.2 million, reflecting a strong liquidity position [3][6]. Outlook - The company anticipates a production guidance for 2026 between 60 – 65 MMcfd, a decrease from 2025 due to field decline and seasonal variations [10]. - There is ongoing uncertainty regarding the Songo Songo License extension application, which is critical for the company's long-term sustainability in Tanzania [11][12].

Core Viewpoint - G2 Goldfields Inc. has successfully obtained shareholder approval for the spin-out of its non-core assets into G3 Goldfields Inc., a wholly owned subsidiary, through a plan of arrangement under the Canada Business Corporations Act [1][4]. Voting Results - A total of 190,251,811 G2 Shares were voted, representing approximately 74.03% of all outstanding shares [2]. - The election of directors received significant support, with J. Patrick Sheridan receiving 99.21% approval and Daniel Noone receiving 96.69% [3]. - The approval for the spin-out plan was overwhelmingly supported, with 99.96% of votes cast in favor [3]. Spin-Out Update - The final court hearing for the spin-out approval is scheduled for December 3, 2025, and the completion is expected in Q1 2026, pending regulatory approvals [4]. - G2 will transfer its interests in non-core assets to a Guyanese subsidiary of G3 and provide approximately C$15 million in cash to meet G3's working capital needs [5]. Share Distribution - G2 shareholders will receive one G3 Share for every two G2 Shares held as of the effective date of the spin-out [5]. - Only shareholders of G2 as of the close of business on the effective date will be entitled to receive G3 Shares, with no change in their holdings in G2 as a result of the spin-out [5]. Company Overview - G2 Goldfields focuses on finding and developing gold deposits in Guyana, with a history of discovering over 10 million ounces of gold in the Guiana Shield [7]. - The company announced an updated mineral resource estimate for the Oko property, highlighting significant inferred and indicated gold resources [7][11].

Core Viewpoint - Nyxoah is actively participating in the Piper Sandler 37th Annual Healthcare Conference, showcasing its innovative solutions for Obstructive Sleep Apnea (OSA) treatment [1]. Company Overview - Nyxoah is a medical technology company focused on developing and commercializing innovative solutions for OSA, with its lead product being the Genio system, which is a leadless and battery-free hypoglossal neurostimulation therapy [3]. - The company aims to improve the quality of life for OSA patients, allowing them to enjoy restful nights [3]. Product Development and Regulatory Approvals - The Genio system received its European CE Mark in 2019 following the successful completion of the BLAST OSA study [4]. - Nyxoah has completed two successful IPOs, one on Euronext Brussels in September 2020 and another on NASDAQ in July 2021 [4]. - The company expanded its therapeutic indications to include Complete Concentric Collapse (CCC) patients after positive outcomes from the BETTER SLEEP study, which are currently contraindicated in competitors' therapies [4]. - Nyxoah announced positive results from the DREAM IDE pivotal study and received FDA approval for a subset of adult patients with moderate to severe OSA, specifically those with an Apnea-Hypopnea Index (AHI) of 15 to 65 [4].

Core Viewpoint - Quantum BioPharma Ltd. is involved in a significant legal battle against CIBC and RBC, alleging stock market manipulation through "stock spoofing," with a lawsuit amounting to USD $700 million [2][4]. Company Overview - Quantum BioPharma is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative and metabolic disorders, including its lead compound, Lucid-MS, which aims to prevent and reverse myelin degradation associated with multiple sclerosis [5]. - The company retains a 19.86% ownership stake in Unbuzzd Wellness Inc., which is linked to its product unbuzzd™, and has a royalty agreement that could yield up to $250 million [5]. Legal Context - The ongoing lawsuit against CIBC and RBC is based on allegations that these banks facilitated stock spoofing, with claims that over 16 million illegal orders were placed through their platforms [4]. - The investigative series by CTV News highlights the broader implications of stock spoofing on retail investors and the integrity of the market [2][4].

Core Insights - Vow ASA's primary insiders have made significant share purchases, indicating confidence in the company's future performance [1] Insider Transactions - Thomas Fredrick Borgen, chair of the board, purchased 300,000 shares [1] - Tbfconsulting AS, associated with Thomas Fredrick Borgen, acquired 81,101 shares [1] - Egil Haugsdal, board member, bought 200,000 shares [1] - Cecilie Brænd Hekneby, CFO, purchased 1,140,000 shares [1] - Ulf Tore Hekneby, a close associate of the CFO, acquired 771,000 shares [1] - Ulrik Hekneby, another close associate of the CFO, purchased 65,000 shares [1]